What is Regeneron Pharmaceuticals's capex?

Regeneron Pharmaceuticals (REGN) reported capex of $230.6M in Q1 2026.

How has Regeneron Pharmaceuticals's capex changed year-over-year?

Regeneron Pharmaceuticals's capex increased by 0.6% year-over-year, from $229.3M to $230.6M.

What is the long-term trend for Regeneron Pharmaceuticals's capex?

Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's capex has grown at a 13.0% compound annual growth rate (CAGR), from $551.9M to $898.4M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Regeneron Pharmaceuticals REGN CapEx

CapEx at other companies

Merck & Co.MRK

$991M-25.4%

AmgenAMGN

$712M+73.2%

Celldex TherapeuticsCLDX

$1.64M+518%

Nektar TherapeuticsNKTR

$18K+800%

GlaukosGKOS

$3.96M+104%

EyePoint, Inc. EYPT

$997K+261%

Other financials

Income statement

See full

Revenue$3.6B+19.0%

Operating income$642.9M+8.7%

Net income$727.2M-10.1%

EPS (diluted)$6.75-7.2%

Balance sheet

See full

Cash & equivalents$3.0B-4.0%

Total debt$2.7B+0.1%

Total equity$31.4B+6.9%

Total assets$40.9B+8.9%

Cash flow

See full

Operating cash flow$1.1B+3.2%

Free cash flow$848.3M+4.0%

Valuation

See full

Market cap$65.01B+18.1%

Enterprise value$64.75B+18.5%

P/E14.7×+2.5×

P/S4.4×+0.5×

Profitability

See full

Gross margin93.9%—

Operating margin24.3%-2.9pp

Net margin29.6%-2.3pp

FCF margin27.6%+5.5pp

Returns & leverage

See full

Return on equity14.5%-1.4pp

Debt / equity0.1×0.0×

Current ratio3.6×-1.4×

Where this comes from

Reported directly by Regeneron Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Regeneron Pharmaceuticals's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Regeneron Pharmaceuticals's capex?: Regeneron Pharmaceuticals (REGN) reported capex of $230.6M in Q1 2026.
How has Regeneron Pharmaceuticals's capex changed year-over-year?: Regeneron Pharmaceuticals's capex increased by 0.6% year-over-year, from $229.3M to $230.6M.
What is the long-term trend for Regeneron Pharmaceuticals's capex?: Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's capex has grown at a 13.0% compound annual growth rate (CAGR), from $551.9M to $898.4M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.